Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_provenance.
- NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_assertion description "[Here, we investigated the oncolytic potential of two commercially available live attenuated vaccines, Moraten measles and Jeryl-Lynn mumps, in a murine model of intraperitoneal human ovarian cancer and compared their efficacies against a recombinant oncolytic measles virus (MV-CEA) that is being tested in a phase I clinical trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_provenance.
- NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_assertion evidence source_evidence_literature NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_provenance.
- NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_assertion SIO_000772 15746945 NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_provenance.
- NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_assertion wasDerivedFrom befree-20140225 NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_provenance.
- NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_assertion wasGeneratedBy ECO_0000203 NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP862267.RABXleYA1pBxcOX28FHlXhYKJ0vRe9wp_aN7eWIf9B1Rw130_provenance.